Merck (MRK) Pauses Enrolment in HIV-1 Prevention Studies
Merck MRK announced that it has paused the enrolment of patients in two phase III studies, IMPOWER 22 and IMPOWER 24, which are evaluating investigational oral inhibitor, islatravir (ISL), for pre-exposure prophylaxis (PrEP) in people ... [Read]
Takeda (TAK) CMV Infection Drug Livtencity Gets FDA Approval
Takeda Pharmaceutical TAK announced that the FDA has granted approval to Livtencity (maribavir) for treating post-transplant cytomegalovirus (“CMV”) infection/disease in pediatric patients aged 12 years or older and adults whose disease is refractory to treatment ... [Read]
BioLife Solutions Ranks 353 Among Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500(TM)
PR Newswire BOTHELL, Wash. , Nov. 17, 2021 /PRNewswire/ — BioLife Solutions , Inc. (NASDAQ: BLFS ), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies (“CGT”) and broader ... [Read]
Apollo Endosurgery Announces Publication of a Multicenter Study of Its X-Tack(R)Endoscopic HeliX Tacking System
Study demonstrates high success rates, ease of use, and economic value in the treatment of GI defects AUSTIN, TX / ACCESSWIRE / November 1, 2021 / Apollo Endosurgery, Inc. (“Apollo”) (NASDAQ:APEN), a global leader in ... [Read]
Sensus Healthcare to Participate in Fireside Chat Hosted by Maxim Group and M-Vest
Fireside Chat with CEO Joe Sardano and CFO Javier Rampolla will be held October 19, 2021 at 11:00 a.m. ET BOCA RATON, Fla, Oct. 15, 2021 (GLOBE NEWSWIRE) — Sensus Healthcare, Inc. (Nasdaq: SRTS ), ... [Read]
Harvard Bioscience Schedules Third Quarter 2021 Earnings Conference Call for November 3, 2021 at 8:00 AM ET
HOLLISTON, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for third quarter ended September 30, 2021, before the market opens on November 3, 2021, and will ... [Read]
Senate Bill Decriminalizing Psychedelics Could Help Reverse Some ‘War on Drugs’ Impacts
The global need for effective mental health treatment has led to the growing push for the legalization of psychedelic therapies, pushing the market into the mainstream. Last week, Michigan Senator Jeff Irwin introduced legislation that ... [Read]
$10 Billion Sackler Opioid Settlement Closes Chapter, Psychedelic Chapter Begins
The damage done by the opioid epidemic has caused families grief and loss, but recent developments in the case against Purdue Pharma will see some restitution for the family. A potential $10 billion will be ... [Read]
New COVID-19 Vaccine Mandates Make Rapid COVID Tests More Essential Than Ever
With the number of new COVID cases surging, fueled by a highly contagious Delta variant and only 50% of the US population having been vaccinated, rapid COVID tests and treatments are more important than ever. ... [Read]
New Study Reveals That High Quality Healthy Plant-Based Diets Cut COVID-19 Risk
A recent study by top researchers at Harvard Medical School and King’s College London has revealed that eating a plant-based diet rich in whole foods can help protect against COVID-19. And the staggering results from ... [Read]